Hadija Trojer
Impact in
-
- IL-33, ST2, and ILC Pathways
- Immunodeficiency and Autoimmune Disorders
- Hematology top 10%
- Autoimmune and Inflammatory Disorders Research
Papers in
-
- Inflammasome and immune disorders 10
- Amyloidosis: Diagnosis, Treatment, Outcomes 2
-
- interferon and immune responses 3
- Immune Cell Function and Interaction 2
- Co-authors
- Helen Jane Lachmann (14 shared papers)Philip Nigel Hawkins (13 shared papers)Dorota M. Rowczenio (10 shared papers)Thirusha Lane (10 shared papers)Anna Baginska (6 shared papers)Paul A. Brogan (6 shared papers)Ebun Omoyinmi (5 shared papers)Juan Ignacio Arostegui (3 shared papers)
- Journals
- Lara D. Veeken (5 papers)Pediatric Rheumatology (4 papers)Blood (1 paper)Arthritis Research & Therapy (1 paper)Arthritis & Rheumatology (1 paper)
- Partner nations
- United KingdomSpainUnited States
In The Last Decade
Hadija Trojer
17 papers receiving 599 citations
Peers
Comparison fields: 5 of 58
- Immunology 158
- Hematology 82
- Infectious Diseases 128
- Nephrology 48
- Modeling and Simulation 29
Countries citing papers authored by Hadija Trojer
This map shows the geographic impact of Hadija Trojer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hadija Trojer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hadija Trojer more than expected).
Fields of papers citing papers by Hadija Trojer
This network shows the impact of papers produced by Hadija Trojer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hadija Trojer. The network helps show where Hadija Trojer may publish in the future.
Co-authors
The 25 scholars most cited alongside Hadija Trojer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 155 | |
| 2 | 2017 | 113 | |
| 3 | 2017 | 80 | |
| 4 | 2013 | 53 | |
| 5 | 2016 | 52 | |
| 6 | 2016 | 49 | |
| 7 | 2018 | 35 | |
| 8 | 2020 | 24 | |
| 9 | 2019 | 17 | |
| 10 | 2020 | 13 | |
| 11 | 2015 | 6 | |
| 12 | 2013 | 5 | |
| 13 | 2015 | 4 | |
| 14 | 2017 | 3 | |
| 15 | 2013 | 1 | |
| 16 | Natural history of hereditary lysozyme amyloidosis | 2010 | 1 |
| 17 | 2015 | 1 | |
| 18 | 2016 | 0 |
About Hadija Trojer
Hadija Trojer is a scholar working on Molecular Biology, Immunology, Pathology and Forensic Medicine, Rheumatology and Infectious Diseases, having authored 18 papers that have together received 612 indexed citations. Recurring topics across this work include Inflammasome and immune disorders (10 papers), interferon and immune responses (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers), Systemic Sclerosis and Related Diseases (2 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (2 papers), Dermatological and Skeletal Disorders (2 papers), Immune Cell Function and Interaction (2 papers) and Infection Control and Ventilation (1 paper). The work is most often cited by research in Immunology (158 citations), Hematology (82 citations), Infectious Diseases (128 citations), Nephrology (48 citations) and Modeling and Simulation (29 citations). Hadija Trojer has collaborated with scholars based in United Kingdom, Spain and United States. Frequent co-authors include Helen Jane Lachmann, Philip Nigel Hawkins, Dorota M. Rowczenio, Thirusha Lane, Anna Baginska, Paul A. Brogan, Ebun Omoyinmi, Juan Ignacio Arostegui, Anna Mensa‐Vilaró and Julian David Gillmore. Their work appears in journals such as Lara D. Veeken, Pediatric Rheumatology, Blood, Arthritis Research & Therapy and Arthritis & Rheumatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.